| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
JP Morgan analyst Lisa Gill maintains Labcorp Hldgs (NYSE:LH) with a Overweight and raises the price target from $291 to $317.
UBS analyst Kevin Caliendo maintains Labcorp Hldgs (NYSE:LH) with a Buy and lowers the price target from $325 to $320.
Labcorp posts Q3 EPS of $4.18 and sales of $3.56 billion, exceeding estimates, while revising 2025 guidance amid strong diagnos...
Tech stocks hit new highs as the Nasdaq 100 rallies 0.7% midday. Investors eye a Fed rate cut, Trump-Xi meeting, and major tech...
Labcorp Hldgs (NYSE:LH) raises FY2025 Adj EPS guidance from $16.05-$16.50 to $16.15-$16.50 vs $16.32 analyst estimate. Lowers F...
Laboratory Corp (NYSE:LH) reported quarterly earnings of $4.18 per share which beat the analyst consensus estimate of $4.13 by ...
UBS analyst Kevin Caliendo maintains Labcorp Hldgs (NYSE:LH) with a Buy and raises the price target from $305 to $325.